The Medivive NAD⁺ Pen is a compounded sterile preparation containing nicotinamide adenine dinucleotide (NAD⁺). It's produced by an FDA-registered 503B outsourcing facility in compliance with current Good Manufacturing Practices (cGMP). Each pen is a 30-day supply (1,000 mg total) designed for subcutaneous (under the skin) administration as prescribed by a licensed clinician.
Yes. Each batch is compounded and sterilized under aseptic conditions in a certified ISO-class cleanroom. Sterility testing and endotoxin testing are performed on every batch before release.
Absolutely. Certificates of Analysis and batch sterility reports are available upon request. These confirm product potency, sterility, and compliance with quality standards.
Keep your pen refrigerated between 2–8°C (36–46°F) at all times.
Do not freeze the pen.
If the pen is left unrefrigerated for a few hours, it remains stable at room temperature for short periods — but prolonged exposure should be avoided to maintain potency.
Each pen is labeled with a Beyond-Use Date (BUD) that reflects validated stability data. Typically, pens are stable for several months under proper refrigeration. Always check the label before use.
Use the pen subcutaneously (under the skin) in areas such as the abdomen or thigh.
For complete illustrated instructions, download the official guide here:
medevive.com/instructions.pdf
Some minor dripping at the injection site is completely normal. To minimize this, keep the needle in place for 10–15 seconds after depressing the plunger. Even with this precaution, a small amount of fluid loss can occur and is not cause for concern.
The solution should be clear and colorless to pale yellow. If you notice cloudiness, particles, or significant discoloration, do not use the pen. Contact your provider or pharmacy for replacement guidance.
Yes. Use a cold-pack travel case to maintain the pen between 36–46°F (2–8°C) during transport. Avoid direct sunlight or freezing.
When flying, keep it in your carry-on bag — not checked luggage.
No. Compounded NAD⁺ is not FDA-approved. It is produced by a registered 503B outsourcing facility for prescription use under professional medical supervision. Compounding allows tailored preparations for patient needs when commercial products are unavailable.
Subcutaneous delivery bypasses the digestive system, providing higher bioavailability and faster systemic absorption than oral NAD⁺ precursors such as NR or NMN. This means more NAD⁺ reaches the bloodstream and target tissues.
Only licensed medical professionals with appropriate credentials (e.g., MD, DO, NP, PA) can prescribe this product. It is dispensed by licensed mail-order pharmacies and intended for patient use under supervision.
No. Each pen is designed for single-patient, multi-use with disposable sterile needles. Use a new sterile needle for each injection. Never share your pen with others.
Simply resume your regular dosing schedule. Do not double up or take extra doses to compensate.
Used pens and needles must be placed in a FDA-cleared sharps disposal container. When full, follow your local pharmacy or health department's disposal instructions.
Consult your prescribing clinician. Many longevity and metabolic programs combine NAD⁺ therapy with other regenerative or peptide therapies, but all combinations should be reviewed for safety and compatibility.